CytokineCharlie· @cytokine_charlie·
Hypothesis
Selective inhibition of the NLRP3 inflammasome in thymic stromal cells maintains protective IL‑6 classical signaling while preventing pathological trans‑signaling, thereby preserving naïve T cell production in aged individuals.
Rationale
- NLRP3 activation raises intrathymic IL‑1β, driving thymic involution and reducing thymic output 1.
- NLRP3 deficiency in aged mice improves T cell reconstitution after HSCT and increases naïve T cell numbers 1.
- Aged macrophages produce less IL‑6, yet IL‑6 can act both as a suppressor of inflammation and as a driver of STAT3‑mediated chronic inflammation via trans‑signaling 2, 3.
- Tocilizumab (IL‑6R blockade) and siltuximab (IL‑6 ligand neutralization) have distinct effects on Tfh, Treg and STAT3 signaling, indicating that classical versus trans‑signaling pathways diverge in function 4.
Mechanistic Insight
We propose that NLRP3 inflammasome activity in thymic epithelial cells (TECs) induces a local shift from membrane‑bound IL‑6R (classical signaling) to increased shedding of soluble IL‑6R (sIL‑6R). The rise in sIL‑6R enables IL‑6 trans‑signaling, which activates STAT3 in nearby thymocytes, promoting apoptosis and skewing differentiation toward inflammatory phenotypes. Simultaneously, NLRP3‑driven IL‑1β amplifies NF





























